2BB score and signals
Syndax Pharmaceuticals, Inc.’s current 2BB score is 53 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|
| Activity | 66 | High |
| Momentum | 54 | Stable |
| Financial strength | 24 | Weak |
| Quality | 98 | Very Strong |
| Risk | 57 | Moderate |
Company facts
| Founded | 2005 |
| Employees | 298 |
| 52-week range | $13.00 – $25.59 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|
| 2027-02-24 | — | -0.4477 | — | $98.99M |
| 2026-10-29 | — | -0.4844 | — | $84.50M |
| 2026-08-04 | — | -0.4493 | — | $80.91M |
| 2026-04-30 | -0.48 | -0.5937 | $64.86M | $71.85M |
Related companies